Board & Staff
Board of Directors
Members of our Board of Directors include ovarian cancer survivors, relatives and friends of women who died from the disease and leaders in the business community. Read about the Board of Directors
Scientific and Medical Advisory Board (SMAB)
Members of our Scientific and Medical Advisory Board are respected leaders in research and on treating women with ovarian cancer. Read about the Scientific and Medical Advisory Board
Our staff work tirelessly throughout the year to advance the interests of women with ovarian cancer. Click here to meet our team.
Diane Rader O’Connor, President
An ovarian cancer survivor since 2002, Diane Rader O’Connor is president and co-founder of the Ovarian Cancer Alliance of Oregon and SW Washington, a Partner Member of the Ovarian Cancer National Alliance. She has served on the board of directors for the Ovarian Cancer National Alliance since 2006, where she currently chairs the Governance and Service Programs Committees.
She has been an integral part of the Ovarian Cancer National Alliance’s Survivor’s Teaching Students: Saving Women’s Lives® program since 2004 and has recruited and prepared survivors to speak at the Oregon Health and Science University as well as local nursing schools. She has served as a Consumer Reviewer for the Department of Defense Ovarian Cancer Research Project. Diane also helped create the SW Washington Cancer Center’s gynecologic cancer support group in 2003.
In 2000, Diane retired from a 32-year career as a counselor and educator in the Vancouver, WA, public school system. She has been married for 40 years and has two adult sons and two granddaughters.
Robin Cohen, President-Elect
Drexel Hill, PA
Robin Cohen has been the Executive Director and Co-Founder of the Sandy Rollman Ovarian Cancer Foundation for 10 years. She is an oncology nurse at Lankenau Hospital in the Philadelphia area. She is a member of the Oncology Nursing Society, the Society of Gynecologic Nurse Oncologists, Sigma Theta Tau Honor Society and the Cambridge WHO’s WHO. In 2007, she was recognized as one of the 75 Greatest Living Philadelphians.
Jennifer Bisacre, Treasurer
Jennifer L. Bisacre, CPA, CFE earned her bachelor’s degree in finance from the University of Maryland in College Park. She is an audit Manager with Gelman, Rosenberg & Freedman CPAs and has been with the firm since graduation. She concentrates her skills in auditing and accounting for tax-exempt organizations.
Ms. Bisacre travels internationally on behalf of her clients, most recently completing trips to Oslo, Paris, Port-au-Prince, Kigali and Juba. Ms. Bisacre is a member of the American Institute of Certified Public Accountants, the Greater Washington Society of CPAs and the Association of Certified Fraud Examiners.
Alison Stautberg, Secretary
New York, NY
Alison Stautberg works for Cyrus Capital Partners, a 2.5 billion dollar hedge fund based in New York and London that focuses on the distressed debt market. Before joining Cyrus Capital, Alison managed the Abdul-Aziz Family Foundation for part of the Saudi Royal Family. Alison earned her BA in International Affairs from The George Washington University in 2007 and her MPA from New York University in 2010.
Alison was awarded fellowships from a variety of institutions including the Embassy of Israel, the Governor’s School of New Jersey, Public Policy and International Fellows at Carnegie Mellon University, IHS at the University of California at Berkeley and Susan Schiffer Stautberg Leadership Fellows. In addition to serving as a member of the Board of Directors, Alison founded the Junior Committee of Ovarian Cancer National Alliance in 2009. She is a past Treasurer and Board Member of Dusan Tynek Dance Theatre, and former Junior Board member of The Family Center.
Judith S. Abrams, President Emerita
New York, NY
Judith Abrams has spent 30 years in private banking, including 21 years at Bankers Trust (then Deutsche Bank) as Managing Director of Private Wealth Management and three years as a Senior Client Consultant with Sontag Advisory, LLC, a registered investment advisor. She is on the Advisory Board of the Susan Schiffer Stautberg Leadership Foundation and is a member of the Committee of 200 and the Belizean Grove.
Her community activities have included participation in programs with Women Unlimited, Habitat for Humanity and Global Volunteers. She was a regularly featured columnist for The Jewish Week and a participant in the Trinity Church Wall Street Dialogues. Judy lost her dear friend, Judy H. Mello, to ovarian cancer, and is herself a breast cancer survivor. She resides with her husband Ralph in New York City.
New York, NY
Jenny Allen’s essays and articles have appeared for years in many magazines, including The New Yorker, The New York Times, New York, Vogue, Esquire, More, Huffington Post and Good Housekeeping. Recent essays appear in Disquiet, Please! a new anthology of humor pieces from the New Yorker, and in In The Fullness of Time: 32 Women on Life After 50 (Simon & Schuster). She is the author of a book of fables for grown-ups calledThe Long Chalkboard, illustrated by her husband, Jules Feiffer.
She performs stand-up comedy in Manhattan, has appeared in Spalding Grey: Stories Left to Tell, and is a participating storyteller for The Moth. Her one-woman play about ovarian cancer, I Got Sick Then I Got Better was first performed on Martha’s Vineyard in the summer of 2007; director James Lapine then collaborated with Allen and with Darren Katz on shaping and expanding the material. New York Theatre Workshop produced the show in 2009, extending it three times.
I Got Sick Then I Got Better has been seen in theaters, hospitals, universities and at cancer conferences around the country. Ms. Allen received the 2010 “It’s Always Something” award from Gilda’s Club NYC. She has two children, Halley, an actress, and Julie, a high school student, as well as a stepdaughter, Kate. For a calendar of future performances, and for booking inquiries, visit jennyallenwrites.com
Catherine A. Baum
Catherine A. Baum is a managing partner of MARCAT Group LLC, an independent consulting/advisory firm specializing in business, market, and customer development. As a consultant, Ms. Baum worked with Waterford Development where she oversaw the sales and marketing efforts for its boutique condominium, office and retail endeavors in Arlington, Falls Church, and Leesburg, Virginia.
Catherine previously served as Division Manager and President of the Washington Division of Drees Homes, and Executive Vice President of the Stanley Martin Companies. She graduated from George Mason University with a BS in Management in 1981. Catherine serves as a District representative to the Fairfax County Commission on Women as well as the Human Relations Advisory Committee of the Fairfax County School Board.
She is the Chair of the George Mason University Libraries Advisory Board, a past president of the Reston Board of Commerce and a mentor in the Women’s Center “I Can” program.
Jennifer Coken has spent 25 years as a political and legislative strategist running campaigns at the federal, state and local levels, and as a visionary entrepreneur starting non-profit organizations and raising millions of dollars.
Jennifer has worked for the Public Interest Research Groups, the National Parks Conservation Association, the Congressional Hunger Center, the Gore Lieberman Campaign and the Virginia Statehouse Caucus. She was one of the founders of Hands on DC, and assisted with the creation of the Southeast Tennis and Learning Center.
Jennifer was a co-founder of the Colorado Blue Flower Fund to elect progressive, pro-choice women to state and local offices. In 2010 Jennifer was a candidate for the Statehouse but lost in Colorado’s most contested primary election. Jennifer just finished writing her first book, “When I Die, Take My Panties: Or, What Do Chemotherapy, Tap-Dancing and Candy Corn Have In Common,” a memoir about her mother’s eventual death from ovarian cancer in 2011
Denise K. Fletcher
New York, NY
Denise Fletcher has been a leader at public and private global companies and not-for-profits. Currently she serves on the boards of Unisys Corporation, The Mazars Group (Paris), and Inovalon.
Previously she served on the public company boards of Sempra Energy, Orbitz, and Software Etc. Stores as well as the board of The Hospital Group (private U.K). She served on the boards of Girl Scouts/USA, YWCA/NYC, Flying Heritage Collection Museum and the Alumni Executive Council of the Kennedy School of Government at Harvard. Denise was Executive Vice President, Finance of Vulcan Inc., Microsoft co-founder Paul Allen’s multi-billion dollar investment company.
A Phi Beta Kappa graduate of Wellesley College, Denise holds a Master’s from Harvard University. She is a member of the Council on Foreign Relations, the Economic Club of New York, the Academy of Women Achievers, the Wellesley Business Leadership Council, Financial Executives International, The Harvard Club of New York City and the Women’s Forum of New York.
Veronica Jordan, PhD
Veronica Jordan has broad business experience in health care and life science-based companies. For much of her career, she has been involved in the discovery and development of new drugs and other health care products, and has provided senior leadership to numerous clinical trial programs.
Veronica’s experience includes building early-stage companies and management of larger international organizations, with functional expertise covering general management, sales and marketing, business development and technical operations. She holds a BA in biochemistry from Cambridge University and a PhD in biochemistry/cell biology from Oxford University. She has conducted post-doctoral research at the Dana Farber Cancer Institute, Harvard Medical School.
Jaime Berman Matyas is the Executive Vice President and Chief Operating Officer of the National Wildlife Federation. She earned her undergraduate degree from the University of Pennsylvania. Most recently she was one of 1000 people trained by Vice President Gore’s The Climate Project.
She was honored in 2006 by the Washington Business Journal with their prestigious Women Who Mean Business award and in 2008 by Jewish Women International’s Women to Watch. She lives in Maryland with her husband and two daughters. She was introduced to the Ovarian Cancer National Alliance by a friend battling ovarian cancer.
Joan is the Chairman and CEO of Middle Kingdom Business Consultants LLC, (MKBC). MKBC concentrates on strategic consulting for a number of multinational firms with business activities in China. MKBC has offices in Washington, DC and Beijing, China, where her company leverages governmental relationships in both countries on behalf of company clients. Joan has visited China over 75 times and serves as an advisor to several Chinese cities and Provinces.
Joan served in a number of senior international trade positions in the U.S. government as well as the White House and U.S. Senate. Subsequently, she was a senior partner in Baker Donelson. She received her BA from Marymount College in New York, her MA in Government and Public Administration from The American University, and her JD from the Washington College of Law at The American University. Joan was the first woman member of Baker Donelson’s Board of Directors, as well as the first woman Staff Director of the U.S. Senate.
She is currently on the Boards of China’s NABI Investment Company, the Forum for International Policy, the Atlantic Council, and is a member of the Council on Foreign Relations, the American and District of Columbia Bar Associations.
Matthew Neal Miller
Matthew Neal Miller is a management consultant with close to twenty years’ experience in the public and private sectors. Matthew currently works in the Advisory Practice of PwC where he specializes in strategic planning, organizational performance management and change management and transformation.
He has led major engagements and has been a career manager to multiple staff. Prior to coming to PwC, Matthew worked at Booz Allen Hamilton and the U.S. Department of Education. He has an MBA from Johns Hopkins University, a BA with Honors from Wesleyan University and was a visiting student at the University of Oxford.
In addition, Matthew is certified as a Change Management Advanced Practitioner from Georgetown University’s McDonough School of Business. He has served as an adjunct instructor at Georgetown University’s School of Continuing Studies and is a member of the Project Management Institute. Matthew’s mother died of ovarian cancer in 1994.
A respected business leader and visionary, Keith Mirchandani is President, CEO and Founder of Tristar Products Inc. Since starting up Tristar in 1993, he has built the company into an award-winning market leader, with over $1 billion in sales. His marketing savvy, integrity, creativity and business expertise has been pivotal to Tristar’s success at branding and selling 20-plus products in over 100 countries around the globe. He oversees product development, infomercial production, strategic partnerships and leads the overall direction of the company.
Ronald D. Alvarez, MD
Dr. Alvarez is Professor and Vice-Chairman in the Department of Obstetrics and Gynecology, and Director of the Division of Gynecologic Oncology at the University of Alabama at Birmingham (UAB). He holds the Ellen Gregg Shook Culverhouse Chair in Gynecologic Oncology and is Senior Scientist at the UAB Comprehensive Cancer Center. Dr. Alvarez received his medical degree from the Louisiana State University Medical Center in New Orleans.
His postgraduate training included a residency in Obstetrics and Gynecology and fellowship in Gynecologic Oncology at the University of Alabama at Birmingham School of Medicine. Dr. Alvarez’s research interests include novel therapeutics for ovarian cancer and cervical cancer screening and prevention. He has published over 150 articles in various peer-reviewed journals including the Journal of Gynecologic Oncology, Clinical Cancer Research, and Molecular Therapeutics.
He serves as co-chair of the Protocol Development Committee for the Gynecologic Oncology Group. Dr. Alvarez has been an active member of several scientific review panels, including the Clinical Oncology Study Section of the National Cancer Institute and the Department of Defense Ovarian Cancer Research Program.
Deborah K. Armstrong, MD
Dr. Armstrong is Associate Professor of Oncology and Associate Professor of Obstetrics and Gynecology at the Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins School of Medicine, as well as an active staff member in the hospital’s Oncology Department. She is currently on the editorial review board and peer review panels of publications such as Gynecologic Oncology and Journal of the National Cancer Institute.
Dr. Armstrong also holds positions on committees with the American Society of Clinical Oncology and the Gynecologic Oncology Group. Her research interests in ovarian cancer lie in the genetic aspects of the disease as well as interperitoneal (IP) therapy, biological therapy, and immunologic means of treatment.
Her contributions to the field of ovarian cancer include leading the IP therapy effort, developing new therapeutic cancer treatments, and directing a genetic counseling service at Johns Hopkins to identify and help at risk patients.
Robert Clinton Bast, Jr., MD
Dr. Bast is Vice President for Translational Research, Internist and Professor of Medicine, and the Harry Carothers Wiess Distinguished University Chair for Cancer Research at the University of Texas M.D. Anderson Cancer Center. Dr. Bast is currently on the editorial and advisory boards of many medical journals including Cancer and Clinical Cancer Research and co-edits Cancer Medicine, a major textbook of oncology.
Dr. Bast’s research interests include understanding the molecular aspects of ovarian cancer, developing an effective strategy for early detection, and individualizing ovarian cancer treatments. His contributions to the field of ovarian cancer research involve development of the CA-125 biomarker test, the characterization of molecular abnormalities in ovarian cancer, and the discovery of ARHI and other imprinted tumor suppressor genes.
Robert Allen Burger, MD
Dr. Burger is Professor of Surgical Oncology—Section of Gynecologic Oncology and Director of the Women’s Cancer Center at Fox Chase Cancer Center in Philadelphia. He earned his undergraduate degree in biochemistry at Harvard University, received his MD at New York University, completed a residency in Obstetrics and Gynecology at the University of Pennsylvania and finished a four-year fellowship in Gynecologic Oncology at the University of California, Irvine.
Dr. Burger’s principal research interest is in ovarian cancer therapy, reflected in many of his 73 peer-reviewed publications and seven book chapters. His current research program involves studies of molecular targeted therapeutics and novel primary prevention strategies. He is principal investigator for phase II and phase III trials of anti-angiogenic therapy in patients with ovarian cancer.
Dr. Burger serves on three committees of the national Cancer Institute’s Gynecologic Oncology Group (GOG) and is co-chair for the GOG Developmental Therapeutics Committee.
Robert Coleman, MD
Dr. Coleman was recruited back to the M.D. Anderson faculty in 2004 to help expand and coordinate the Department of Gynecologic Oncology clinical therapeutics program. Finishing the institution’s Gynecologic Oncology fellowship in 1993, he has distinguished himself as a key opinion leader in cancers of the female genital tract. He has authored and co-authored more than 400 scientific publications, including more than 130 peer-reviewed articles, numerous book chapters, monographs, invited articles and textbooks.
He is a frequently invited lecturer for national and international conferences and meetings where he continues to foster global scientific collaboration. Dr. Coleman currently serves on the Editorial Board of several peer-reviewed scientific publications. He is an active member of many national organizations including the Society of Gynecologic Oncology, the American College of Surgeons, American Association for Cancer Research and the American Society of Clinical Oncology. He also serves several international organizations, such as the International Gynecologic Cancer Society, European Society of Gynecologic Oncology and the European Society of Medical Oncology.
Dr. Coleman serves as the vice-chairman of the Department of Gynecologic Oncology Clinical Research, Director of Developmental Therapeutics and Research Administration Committees, is a member of the Blanton-Davis Ovarian Cancer Research Program Executive Committee and is a Member of the Board for the Foundation for Women’s Cancer. In June 2010 he was appointed to the Ann Rife Cox Chair in Gynecology and is a member of the M.D. Anderson Cancer Center’s Center for RNA Interference and Non-Coding RNA.
George Coukos, MD, PhD
Dr. Coukos is a tenured Professor in the Division of Gynecologic Oncology and the Director of the Ovarian Cancer Research Center at the University of Pennsylvania. He earned an M.D. (cum laude) from the University of Modena (Italy), and a Ph.D. (Reproductive Biology) from the University of Patras School of Medicine (Greece). He is author of more than 150 publications; recipient of numerous awards for research in ovarian cancer; executive member of national and international organizations and foundations devoted to cancer research; and continuously recognized by Best Doctors in America for Cancer since 2007.
The Ovarian Cancer Research Center (OCRC) was launched in January 2007 under his leadership and with support from the University of Pennsylvania School of Medicine and the Department of Obstetrics and Gynecology. The mission of the OCRC is to improve the length and quality of life of women at risk for or with a diagnosis of ovarian cancer through innovative and multidisciplinary research in the areas of detection, prevention or therapy, and through rapid clinical translation of laboratory discoveries. The OCRC has also an educational mission, to develop the next generation of ovarian cancer translational and clinical investigators.
Daniel Cramer, MD, Sc.D.
Dr. Cramer is Professor of Obstetrics, Gynecology, and Reproductive Biology in the Department of Obstetrics and Gynecology at Harvard Medical School at Brigham and Women’s Hospital in Boston, Massachusetts.
He heads an ovarian cancer Specialized Program of Research Excellence in Boston, a program of the National Cancer Institute (NCI) that promotes the transfer of cancer research to the clinical setting; is a member of the Early Detection Research Network, an NCI program aimed at developing biomarker and technology for early detection; and actively researches environmental, reproductive, and genetic factors in ovarian cancer.
His main research interest is the epidemiology of ovarian cancer. Dr. Cramer’s contributions include being the first to present data on use of cosmetic talc in the genital area being a risk factor for ovarian cancer and the first to suggest that immune pathways mediate many risk factors for the disease.
Barbara A. Goff, MD
Dr. Goff is Professor of Obstetrics and Gynecology, Adjunct Professor of Surgery, and the Gynecologic Oncology Division Director at the University of Washington School of Medicine. She is also an affiliate investigator at the Fred Hutchinson Cancer Research Center. Dr. Goff is currently on a number of boards, including the National Board of Medical Examiners and the American Board of Obstetrics and Gynecology, as well as the editorial board of Gynecologic Oncology.
Her interests in ovarian cancer include early detection, teaching and evaluating surgical skills, clinical trials for gynecologic malignancies, and biomarkers of chemoresistance. Her contributions to the field of ovarian cancer research include identifying early detection methods.
Beth Y. Karlan, MD
Dr. Karlan holds the Board of Governors’ Endowed Chair in Gynecologic Oncology, she is the Director of the Women’s Cancer Research Institute at the Samuel Oschin Cancer Institute, Director of the Division of Gynecologic Oncology and the Gilda Radner Cancer Detection Program at Cedars-Sinai Medical Center. Dr. Karlan is Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Karlan received her medical degree from Harvard Medical School and Harvard-M.I.T. Program in Health Sciences and Technology.
Her postgraduate training included a residency in Obstetrics and Gynecology at Yale-New Haven Hospital, a postdoctoral research fellowship at Yale University School of Medicine and a Gynecologic Oncology Fellowship at UCLA. She has published over 150 articles in peer reviewed journals including Gynecologic Oncology, Cancer, Cancer Research and Journal of Clinical Oncology. Dr. Karlan has served as the President of the Society of Gynecologic Oncologists and as a member of the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology.
Dr. Karlan was appointed Editor-in-Chief to the Gynecologic Oncology Journal in 2008. Her research interests include early detection, biomarker discovery, inherited susceptibility, and targeted therapy. Dr. Karlan’s contributions include early detection, recognizing the importance of awareness, and individualizing therapeutic approaches of treatment.
Dineo Khabele, MD
Dr. Khabele is Assistant Professor of Obstetrics and Gynecology, Director of Gynecologic Oncology and Director of the Women’s Cancer Research Laboratory at Meharry Medical College. She is also Assistant Professor of Cancer Biology at Vanderbilt University. Dr. Khabele is currently on the Quality Assurance Committee and Cancer Committee at Meharry Medical College, and an advisory board member of the Witness Project, a cancer awareness program directed at African American women.
Her interests in ovarian cancer include awareness, patient care and health disparities among women with cancer — particularly African American women. Her contributions include the initiation of a gynecologic oncology program at Meharry Medical College focused on patient care, research, and community outreach; and raising awareness about gynecologic cancers.
Robert J. Kurman, MD
Dr. Kurman is the Richard Telinde Distinguished Professor of Gynecologic Pathology at The Johns Hopkins School of Medicine. He is a reviewer of medical publications such as Cancer and American Journal of Obstetrics and Gynecology, where he is also on the editorial advisory board. His research interests include pathogenesis with implications for early detection and treatment for both ovarian cancer and borderline tumors. Dr. Kurman’s contributions to the field include establishing that there are dual pathways for the development of ovarian cancer with precursor lesions and genetic changes, and clarifying the relationship between borderline tumors and invasive carcinoma.
Judith Reichman, MD
Dr. Reichman is considered to be one of the leading voices in America on women’s health issues. She has been a contributing editor to the TODAY Show twice each month for over a decade, covering a wide variety of subjects and health issues related to women. Currently, Dr. Reichman has a thriving practice and teaches gynecology, and menopausal care at Cedars-Sinai Medical Center and UCLA in Los Angeles.
As the author of the bestsellers I’m Not In The Mood – What Every Woman Should Know About Improving Her Libido, I’m Too Young to Get Old: Health Care for Women After Forty, Relax, This Won’t Hurt: Painless Answers to Women’s Health Questions and her most recent book Slow Your Clock Down: The Complete Guide to a Healthy, Younger You. Dr Reichman is also a contributing editor for the LA Times Magazine. She has been the medical guest on several Oprah shows, was the medical commentator for “Life & Times,” KCET and Public Television and has made numerous television appearances on health segments for PBS, ABC “Evening News with Peter Jennings,” CNN, “Regis and Kathy” and ABC “Good Morning America.”
Her many appearances on such programs have established her as one of the leading voices in women’s health care today. Dr. Reichman received her bachelor’s degree, magna cum laude, from Barnard College in 1966, and her M.D., magna cum laude, from the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. She completed her residency training in obstetrics and gynecology at the University of Chicago. Dr. Reichman lives in Los Angeles where she has a Gynecology and Menopausal Care practice. She is married to Gil Cates, the managing director of The Geffen Playhouse. They have 6 children and one dog (who resides with them).
Steve Skates, PhD
Dr. Skates is Associate Professor of Medicine (Biostatistics) at Harvard Medical School and Massachusetts General Hospital (MGH), a member of the MGH Cancer Center and of the Dana Farber/Harvard Cancer Center. He serves on the Trial Management Committee of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), and has served on grant review panels for the US National Cancer Institute, the UK Medical Research Council, and the Australian National Health and Medical Research Council.
His research interests in ovarian cancer include developing personalized screening tests using a woman’s past test results, designing and implementing optimal screening programs, discovering new biomarkers for early detection, and developing statistical methods for combining the information in multiple biomarkers.
His contributions to the field of ovarian cancer research include the risk of ovarian cancer algorithm which is currently being tested in a randomized prospective trial (UKCTOCS) for normal risk postmenopausal women, in the NCI’s Cancer Genetics Network (CGN) trial of women at elevated risk, in the UK Familial Ovarian Cancer Screening Study (UKFOCSS), and the US Normal Risk Ovarian Screening Study (NROSS), and developing methods to combine ovarian cancer biomarkers CA125 and HE4 for testing women with pelvic masses.
Anil K. Sood, MD
Dr. Sood is Professor and Vice Chair for Translational Research in the Departments of Gynecologic Oncology and Cancer Biology and co-director of the Center for RNA Interference and Non-Coding RNA at the M. D. Anderson Cancer Center.
He is also Director of the multi-disciplinary Blanton-Davis Ovarian Cancer Research Program. Dr. Sood’s research is focused in three main areas: 1) effects of neuroendocrine stress hormones on ovarian cancer growth and progression, 2) development of new strategies for in vivo siRNA delivery, and 3) development of novel anti-vascular therapeutic approaches.
Dr. Sood has received major recognition for his research accomplishments including the Hunter Award, the Margaret Greenfield/Carmel Cohen Excellence in Ovarian Cancer Research Prize, and the GCF/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher. Dr. Sood is an elected member of the American Society for Clinical Investigation and an elected fellow of the American Association for the Advancement of Science.
Alice Spinelli, MSN, ARNP
Ms. Spinelli is a Gynecologic Oncology Nurse Practitioner with Gynecologic Oncology of Brevard in Florida. She is a past president of the Society of Gynecologic Nurse Oncologists (2002-2004), as well as a member of the Oncology Nursing Society, and the cancer control co-chair of the American Cancer Society-Brevard Unit. Her participation also extends to the Gynecologic Oncology Foundation, and Ovarian Cancer Alliance of Florida/Space Coast, a partner organization of the Alliance, where she is the co-facilitator.
Ms. Spinelli’s interests in ovarian cancer include treating and caring of patients, cancer genetics and genetic mutations such as the BRCA gene (breast cancer genes 1 and 2). Among her most significant contributions is the development of a module on ovarian cancer for nursing students that utilizes ovarian cancer survivors.
Calaneet H. Balas - Chief Executive Officer
Lisa Mauti - Vice President of Cause Marketing
Amanda Davis - Director of Marketing and Communications
Molly Gascoigne - Director of Development
Laura M. Koontz, PhD - Director of Policy
Alison Silberman - Director of Field Engagement
Rachel Solomon - Office Support Manager
Catie Dugan - Community Engagement Associate